27.15 USD
▲-0.26+6.01%
盘后 25.29 -1.25%
2026-08-03
市值
$4.65B
市盈率
12.31
EPS
2.20
股息率
—
52 周区间
19.69 – 28.35
成交量
2.44M
Beta
0.80
目标价
32.95
52W 低 19.6952W 高 28.35
价格走势
公司简介
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America. The company offers NUPLAZID (pimavanserin), a selective serotonin inverse agonist/antagonist for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis; and DAYBUE, a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 to treat the symptoms of Rett syndrome by reducing neuroinflammation and supporting sy...